Esophageal Tumor Cells
Esophageal cancer ranks among the most aggressive gastrointestinal malignancies, with two predominant histological subtypes: Esophageal Squamous Cell Carcinoma (ESCC) and Esophageal Adenocarcinoma (EAC). These tumors exhibit profound intratumoral heterogeneity, driven by complex genetic and epigenetic alterations, leading to rapid progression, early metastasis, and notorious resistance to conventional therapies. The development of effective treatments is hampered by a limited understanding of its dynamic biology.
Our curated portfolio of esophageal tumor cell lines serves as an indispensable preclinical toolkit. These models encapsulate the molecular diversity of the disease, enabling researchers to deconstruct tumorigenic pathways, validate novel therapeutic targets, and engineer advanced in vitro systems that recapitulate the tumor microenvironment and therapy-resistant niches.
Clinically Relevant Molecularly Annotated Functionally Validated Globally Accessible
Key Features & Expertise
Engineered for Discovery: Why Our Esophageal Tumor Cell Lines Are the Preferred Choice
A Comprehensive, Subtype-Specific Model System
- An extensive library encompassing the full spectrum of esophageal cancer, from early-stage Barrett’s esophagus-derived lines to advanced, metastatic ESCC and EAC models.
- Models are annotated with critical clinical metadata, including tumor grade, TNM stage, prior treatment history, and patient demographics.
- Includes rare and genetically engineered lines representing understudied molecular subsets, such as those with PI3KCA mutations or FGFR amplifications.
Multi-Omics Characterization for Informed Model Selection
- Each line is accompanied by a detailed molecular passport: whole-exome sequencing data, RNA expression profiles, and key protein marker status ( e.g. , PD-L1, HER2).
- Baseline functional data packages include IC50 values for standard-of-care chemotherapies (Cisplatin, 5-FU, Paclitaxel) and common targeted agents.
- Optimized protocols and performance data for complex applications like 3D organoid formation, invasion assays, and co-culture with immune cells.
Uncompromising Rigor and Dedicated Partnership
- Beyond STR authentication, lines undergo regular whole-genome SNP array analysis to monitor genetic stability and confirm the absence of cross-contamination.
- Manufactured under a quality management system, ensuring traceability, viability guarantee, and sterile, endotoxin-tested fetal bovine serum in media.
- Access to our team of oncology scientists for collaborative experimental design, data interpretation, and custom model development inquiries.
FAQ
Are there esophageal tumor cell lines that model specific stages of disease progression or metastasis?
Yes, our collection includes cell lines derived not only from primary esophageal tumors but also from metastatic sites such as lymph nodes, pleural effusions, and ascites. Comparing the behavior and molecular profiles of matched primary and metastatic cell lines can provide valuable insights into the mechanisms of invasion and metastasis. For example, models established from metastatic lesions may exhibit enhanced migratory and invasive properties in in vitro assays.
What culture conditions are recommended for esophageal tumor cell lines?
Most human esophageal tumor cell lines adhere well and are cultured in standard humidified incubators at 37°C with 5% CO₂. They are typically maintained in RPMI 1640 or DMEM medium, supplemented with 10% fetal bovine serum (FBS). However, specific nutritional requirements or recommended doubling times can vary between lines. Detailed, cell line-specific culture protocols are provided with each product to ensure optimal growth and experimental consistency.
Can these cell lines be used to study the tumor microenvironment (TME) or for co-culture experiments?
Absolutely. Esophageal tumor cell lines are foundational for building more physiologically relevant models. They are commonly used in co-culture systems with cancer-associated fibroblasts (CAFs), immune cells, or endothelial cells to study cell-cell interactions within the TME. Additionally, they are suitable for establishing 3D spheroids or organoids, which better mimic the tumor architecture and can be used to investigate drug penetration, hypoxia, and stromal effects.
Do you provide isogenic pairs ( e.g. , parental and drug-resistant) of esophageal cancer cell lines?
We offer select pairs of esophageal tumor cell lines where one is the parental line and the other is a derived subline with characterized resistance to common chemotherapeutics like cisplatin or 5-fluorouracil. These isogenic pairs are powerful tools for comparative studies aimed at unraveling the molecular mechanisms underlying acquired drug resistance, a major hurdle in esophageal cancer treatment.
How suitable are these cell lines for in vivo xenograft studies?
Many of our esophageal tumor cell lines have been validated for their ability to form tumors in immunodeficient mice ( e.g. , nude or NSG mice), making them excellent models for establishing cell-derived xenografts (CDX). Tumor growth rates, take rates, and histopathology can vary between lines. We recommend consulting the product information or our technical support team for guidance on selecting the most appropriate model for your specific in vivo research objectives.
What support is available for experimental design using these cell lines?
Our dedicated scientific support team is available to assist with experimental design, protocol optimization, and troubleshooting. We can provide guidance on cell line selection based on your research goals, share published application notes, and discuss best practices for assays commonly performed with these models, such as proliferation, migration, invasion, and drug sensitivity testing.